Humana Inc. $HUM Shares Sold by Neuberger Berman Group LLC

Neuberger Berman Group LLC lowered its position in Humana Inc. (NYSE:HUM) by 16.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,959 shares of the insurance provider’s stock after selling 3,516 shares during the quarter. Neuberger Berman Group LLC’s holdings in Humana were worth $4,391,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the business. Revolve Wealth Partners LLC acquired a new position in Humana in the fourth quarter valued at $202,000. Townsquare Capital LLC raised its stake in Humana by 2.8% during the 1st quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider’s stock valued at $597,000 after acquiring an additional 61 shares during the last quarter. Public Sector Pension Investment Board grew its stake in shares of Humana by 8.9% in the 1st quarter. Public Sector Pension Investment Board now owns 16,533 shares of the insurance provider’s stock valued at $4,375,000 after purchasing an additional 1,352 shares during the last quarter. HighTower Advisors LLC increased its holdings in shares of Humana by 8.3% in the first quarter. HighTower Advisors LLC now owns 7,630 shares of the insurance provider’s stock valued at $2,019,000 after purchasing an additional 583 shares during the period. Finally, Horizon Investments LLC raised its stake in shares of Humana by 4.7% during the first quarter. Horizon Investments LLC now owns 2,039 shares of the insurance provider’s stock worth $540,000 after purchasing an additional 92 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Trading Up 0.7%

Shares of Humana stock opened at $268.44 on Monday. The company has a 50-day moving average of $262.41 and a two-hundred day moving average of $258.51. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. The stock has a market cap of $32.29 billion, a PE ratio of 25.16, a price-to-earnings-growth ratio of 1.57 and a beta of 0.46.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a return on equity of 12.86% and a net margin of 1.02%.The business had revenue of $32.65 billion for the quarter, compared to analysts’ expectations of $31.99 billion. During the same quarter in the prior year, the firm posted $4.16 EPS. The company’s revenue was up 11.1% compared to the same quarter last year. On average, research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a $0.885 dividend. The ex-dividend date is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. Humana’s dividend payout ratio (DPR) is currently 33.18%.

Analysts Set New Price Targets

Several equities analysts have issued reports on HUM shares. Guggenheim reissued a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Sanford C. Bernstein raised their price objective on shares of Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Royal Bank Of Canada lifted their price objective on Humana from $283.00 to $322.00 and gave the company an “outperform” rating in a report on Thursday, August 21st. Finally, Jefferies Financial Group raised Humana from a “hold” rating to a “buy” rating and increased their target price for the stock from $253.00 to $313.00 in a research note on Friday, December 5th. Nine research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Humana has an average rating of “Hold” and an average target price of $295.11.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.